Vir Biotechnology Inc (VIR) financials · rev $68.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Vir Biotechnology Inc (VIR) rev $68.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $68.6M | $74.2M |
| Cost of Revenue | $26.0K | $845.0K |
| Gross Profit | $68.5M | $73.4M |
| Operating Income | -$479.3M | -$587.2M |
| Net Income | -$438.0M | -$522.0M |
| EPS (Diluted) | -$3.16 | -$3.83 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.00B | $1.40B |
| Current Assets | $514.1M | $1.04B |
| Cash & Equivalents | $232.2M | $222.9M |
| PP&E | $55.6M | $63.2M |
| Total Liabilities | $237.5M | $248.4M |
| Current Liabilities | $92.8M | $119.7M |
| Shareholders' Equity | $765.3M | $1.15B |
| Retained Earnings | -$1.20B | -$759.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$391.8M | -$446.4M |
| CapEx | $4.83M | $7.30M |
| Investing Cash Flow | $310.4M | $499.4M |
| Financing Cash Flow | $3.79M | $4.39M |
| Net Change in Cash | -$77.6M | $57.4M |
| Free Cash Flow | -$396.6M | -$453.7M |
FAQ
What is VIR P/E and revenue?
Vir Biotechnology Inc (VIR) rev $68.6M.
What is VIR revenue?
Vir Biotechnology Inc last cached revenue is $68.6M (FY2025).
Is VIR profitable?
Vir Biotechnology Inc last cached net income is -$438.0M (FY2025).
What are VIR total assets?
Vir Biotechnology Inc last cached total assets are $1.00B (FY2025).
What is VIR free cash flow?
Vir Biotechnology Inc last cached free cash flow is -$396.6M (FY2025).
Not investment advice. Cached statements, not a live tape.